Dr. David Miguel Padua, MD

Dr. Padua practices at Cedars-Sinai Medical Care Foundation in Beverly Hills, California.

Dr. Padua's NPI, 1083915763, was assigned on November 11, 2010. Dr. Padua graduated from Weill Cornell Medicine in 2010. Dr. Padua's California license number on file is A118834.

Dr. Padua's primary practice is Cedars-Sinai Medical Care Foundation, at 8536 Wilshire Blvd, Beverly Hills, CA 90211 in Los Angeles County. The practice phone is (310) 385-3200.

Dr. Padua's primary practice is Cedars-Sinai Medical Care Foundation in Beverly Hills, California. Dr. Padua is also affiliated with Cedars-Sinai Medical Center. The medical group on file is Cedars-Sinai Medical Group. Dmand AI also links Dr. Padua to 1 more group practice or clinic, 1 ambulatory surgery center and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Padua practices, 3 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Padua's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Padua is board certified in gastroenterology by the American Board of Internal Medicine. Dr. Padua has a license on file in California.

Dmand AI lists acid reflux, colonoscopy, gastroenteritis, gastrointestinal bleeding, hemorrhoids, intestinal diverticulosis, irritable bowel syndrome (IBS) and upper GI endoscopy among the conditions Dr. Padua treats.

CMS data shows 763 Medicare services from Dr. Padua across 13 procedure codes in 2024, for 403 Medicare patients. Medicare paid $70,659 for them.

CMS counts 403 Medicare patients who saw Dr. Padua in 2024. The largest group is 65 to 74, with 201 patients. 75% of them have high cholesterol, and 74% have high blood pressure. 35% are also on Medicaid. Their average risk score is 1.68, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Padua's median patient age at 55, with 58% women.

In 2024, Dr. Padua wrote 1,024 Medicare Part D claims for 269 patients. 86% of them were for generic drugs. CMS names the drug for 919 of them, across 15 drugs with 11 or more claims each, at $652,570 in total drug cost. In 2023, CMS named 725 claims across 12 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Padua for performance year 2024, reported as part of a group. Dr. Padua accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Padua as offering telehealth. CMS counts 117 procedures of colonoscopy by Dr. Padua, more than 83% of the clinicians it reports for that procedure.

Dmand AI links 9 papers to Dr. Padua, published from 2014 to 2019. 2016 was the busiest year, with 2. Dr. Padua's most frequent co-authors are Joseph Rocco Pisegna, MD, Jihane Nejma Benhammou, BS and Dean Ehrlich, MD.

Dmand AI links Dr. Padua to 1 clinical trial. Conditions studied include Colitis, Ulcerative and Colitis.

CMS Open Payments shows 73 general payments to Dr. Padua from 8 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $1,181.

Dr. Padua graduated from Weill Cornell Medicine in 2010.

Dr. Padua is in network with 13 carriers, including Blue Cross Blue Shield of Michigan, United Healthcare and Elevance. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.